Budget Battles
-
Republicans Want Strings Attached to California Disaster Aid
-
Biden Goes Out With a Bang in the Jobs Market
-
Trump Privately Pushes Senators for ‘One Big, Beautiful Bill’
-
Trump Considers Declaring National Emergency for Tariff Rollout
-
Trump Unloads: Grievances, Greenland and the Gulf of Mexico
-
Republicans Divided Over How to Pass Trump’s Agenda
-
Trump Pushes Johnson to Victory as Speaker
-
The Republican Retreat From Market-Based Regulation
By Mark ThomaDuring the debate over the repeal of Obamacare, Republicans made frequent reference to their desire for a “free market” for health care. This is consistent with the GOP’s long-standing support of...
-
Who’s Watching Wall Street? The Feds Turn a Blind Eye to Goldman’s Game
By David DayenWhy are House Republicans working so hard to repeal Wall Street reform when regulators have shown so much willingness to neglect tougher laws?
-
You Get What You Pay For: Banks Spent Billions on Lobbying During the Election
By Pete Schroeder, ReutersBanks and other financial companies expecting big benefits from Republican-led deregulation spent record amounts on lobbying in the last election cycle, according to an advocacy group report released...
-
The One Way Trump’s Administration Really Is a Fine-Tuned Machine
By David DayenThe government-by-mood-ring fluctuations of the Trump presidency have corrected the myth that politicians conjure up devious plans to manipulate the public years in advance. It’s beyond clear that...
-
Trump the Populist Is Trying to Hobble a Champion of the Little Guy
By Ciro ScottiAfter being bested by Hillary Clinton in a primary contest that saw the deck stacked against him by the Clinton Machine, Bernie is back in the Senate doing what he has always done for the past 30-odd...
-
Overhauling Dodd-Frank May Not Succeed, but Also May Not Matter
By Liz PeekNancy Pelosi says President Trump’s call to reshape Dodd-Frank is a “massive con” and that he is putting #WallStreetFirst. Sadly, she has set the tone for Congressional Democrats, siding with...
-
Populist on the Trail, Trump Pivots Toward the Banking Industry
By Rob GarverAfter a campaign spent railing against his opponent’s connections to Wall Street banks and promising to stand up for ordinary Americans against the moneyed interests holding them back, President...
-
In the Trump Administration, Credibility May be a Problem
By Mark ThomaAs a department chair at a university, you learn that a promise from the Dean or anyone else in the administration is good for about five years. That’s approximately how long Deans last, on average,...
-
Here’s Who Wins With Trump’s Order to Slash Regulations
By Rob GarverTrump on Monday morning signed an executive order on Reducing Regulation and Controlling Regulatory Costs. The order is unquestionably a gift to the business community, which constantly complains of...
-
How the GOP Could Wipe Out Federal Regulations in One Easy Step
By Rob GarverA new interpretation of an old law may allow Republicans to wipe out decades of federal regulations. Congressional Republicans have been eager to dismantle many of former president Barack Obama’s...
-
America's Fiscal Future Hinges on Tax Reform
By Lawrence Summers, ReutersHowever the U.S. presidential election turns out, the trifecta of the Bush tax cut expiration, the debt limit ceiling on the horizon once again, and the congressionally mandated sequesters - cuts in...
-
What CEO Musical Chairs Means to the Job Market
By Michelle Hirsch, The Fiscal Timesusiness analysts and search firms say 2012 will be the year of CEO musical chairs, particularly in the health care and financial services industries, which are both coming to terms with new...
-
Dow 13,000-Another Case of Irrational Exuberance?
By Caroline Valetkevitch, ReutersIf upcoming earnings from U.S. retailers are as unimpressive as the rest of the profit season has been, Wall Street could face a tough time justifying a stock market at nine-month highs.
-
What Those New Super Drugs Really Cost
By Merrill Goozner, The Fiscal TimesThe drug industry usually defends the high price on drugs – the latest cancer therapies are tipping the scales at $100,000 a year – by pointing to the large sums it spends on research and development...
-
What the $26 Billion Bank Deal Means to You
The country’s five largest mortgage servicers will pay $26 billion or more to settle investigations into abusive foreclosure practices following the housing bust. What you need to know.